Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
9.12B
Market cap9.12B
Price-Earnings ratio
40.33
Price-Earnings ratio40.33
Dividend yield
Dividend yield
Average volume
240.45K
Average volume240.45K
High today
$311.00
High today$311.00
Low today
$302.29
Low today$302.29
Open price
$306.99
Open price$306.99
Volume
231.79K
Volume231.79K
52 Week high
$319.48
52 Week high$319.48
52 Week low
$127.99
52 Week low$127.99

Stock Snapshot

As of today, Krystal Biotech(KRYS) shares are valued at $309.75. The company's market cap stands at 9.12B, with a P/E ratio of 40.33.

On 2026-06-09, Krystal Biotech(KRYS) stock moved within a range of $302.29 to $311.00. With shares now at $309.75, the stock is trading +2.5% above its intraday low and -0.4% below the session's peak.

Trading activity shows a volume of 231.79K, compared to an average daily volume of 240.45K.

The stock's 52-week range extends from a low of $127.99 to a high of $319.48.

The stock's 52-week range extends from a low of $127.99 to a high of $319.48.

KRYS News

Simply Wall St 17h
This Insider Has Just Sold Shares In Krystal Biotech

Some Krystal Biotech, Inc. ( ) shareholders may be a little concerned to see that the Founder, Krish Krishnan, recently sold a substantial US$7.6m worth of stoc...

This Insider Has Just Sold Shares In Krystal Biotech
TipRanks 4d
Top Krystal Biotech Executives Quietly Unload Major Blocks of Stock

New insider activity at Krystal Biotech ( (KRYS) ) has taken place on June 5, 2026. Claim 55% Off TipRanks Unlock trusted, data-backed investing tools with TipR...

Simply Wall St 4d
Should Strong Vyjuvek Earnings And Analyst Optimism Require Action From Krystal Biotech Investors?

In the past few days, Krystal Biotech reported first-quarter 2026 results that surpassed earnings expectations, powered by stronger-than-anticipated Vyjuvek sal...

Should Strong Vyjuvek Earnings And Analyst Optimism Require Action From Krystal Biotech Investors?

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.